Data / Form D filings / TIXiMED, Inc.
TIXiMED, Inc.: Form D filing
TIXiMED, Inc., a pharmaceuticals company in Birmingham, AL, filed a Form D with the SEC in 2024. The latest, on November 5, 2024, reports $550,000 sold of a $550,000 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1927 1ST AVENUE NORTH, SIXTH FLOOR, Birmingham, AL, 35203
- Phone
- (205) 578-1005
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2043713
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2024 | New notice | $550,000 | $550,000 | 3 | Oct 15, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Michael Goodrich II | Executive Officer, Director | |
| Aneth Michael Shalev | Director |
Every Form D from the week of Nov 4, 2024 · All recent filings in Alabama · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TIXiMED, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.